Korean Transient Ischemic Attack eXpression Registry (KTX registry)

This study has been completed.
Information provided by (Responsible Party):
Yong-Seok Lee, Seoul National University Boramae Hospital
ClinicalTrials.gov Identifier:
First received: May 23, 2013
Last updated: June 6, 2015
Last verified: June 2015
This study is to determine the clinical and neuroimaging characteristics of Transient Ischemic Attacks in Korean populations.

Transient Ischemic Attack

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 90 Days
Official Title: Transient Ischemic Attacks in Korean: Hospital-based, Multi-center Prospective Registry

Resource links provided by NLM:

Further study details as provided by Seoul National University Boramae Hospital:

Primary Outcome Measures:
  • Vascular events including ischemic strokes, myocardial infarctions, cardiovascular deaths [ Time Frame: 90 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Recurrent transient ischemic attacks [ Time Frame: 90 days ] [ Designated as safety issue: No ]

Enrollment: 500
Study Start Date: July 2010
Study Completion Date: August 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
University Hospitals

Inclusion Criteria:

  • Clinical symptoms and signs consistent with transient ischemic attack
  • Subject who admitted hospital within 24 hours after symptom onset
  • Subjects who underwent MRI (including diffusion-weighted images) and MRA (or CT angiography)

Exclusion Criteria:

Transient neurological symptoms due to

  • Migraine aura
  • Basilar migraine
  • Seizures
  • Syncope
  • Peripheral vertigo
  • Transient global amnesia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01870531

Korea, Republic of
Seoul National University Boramae Hospital
Seoul, Korea, Republic of, 156-707
Sponsors and Collaborators
Seoul National University Boramae Hospital
Principal Investigator: Yong-Seok Lee, MD, PhD Seoul National University Boramae Hospital
  More Information

Additional Information:
No publications provided

Responsible Party: Yong-Seok Lee, Professor, Seoul National University Boramae Hospital
ClinicalTrials.gov Identifier: NCT01870531     History of Changes
Other Study ID Numbers: 800-20100046 
Study First Received: May 23, 2013
Last Updated: June 6, 2015
Health Authority: Korea: Institutional Review Board

Keywords provided by Seoul National University Boramae Hospital:
Transient Ischemic Attack

Additional relevant MeSH terms:
Ischemic Attack, Transient
Brain Diseases
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Nervous System Diseases
Pathologic Processes
Vascular Diseases

ClinicalTrials.gov processed this record on February 11, 2016